» Authors » Shridevi Subramaniam

Shridevi Subramaniam

Explore the profile of Shridevi Subramaniam including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 212
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bujang N, Kong Y, Danaee M, Munisamy M, Kaur R, Alagir Rajah H, et al.
JCO Glob Oncol . 2024 Nov; 10:e2400129. PMID: 39509673
Purpose: Beliefs on causes of cancer, although sometimes aligned with known risk factors, may be influenced by personal experiences, cultural narratives, and misinformation. We investigated the prevalence of beliefs on...
2.
Gyeltshen T, Teh H, Loo C, Hing N, Lim W, Subramaniam S, et al.
BMC Public Health . 2024 May; 24(1):1260. PMID: 38720253
Background: Cancer represents a significant global public health challenge, with escalating incidence rates straining healthcare systems. Malaysia, like many nations, has witnessed a rise in cancer cases, particularly among the...
3.
Subramaniam S, Kong Y, Yip C, Thiagarajan M, Pailoor J, Zaharah H, et al.
Ecancermedicalscience . 2023 Apr; 17:1512. PMID: 37113731
The presence of comorbidities has been associated with later stages of breast cancer diagnosis. It is unclear whether biological mechanisms are partly responsible. We examined the association between the presence...
4.
Fnu N, Kuan W, Kong Y, Bustamam R, Wong L, Subramaniam S, et al.
Ecancermedicalscience . 2022 Nov; 16:1449. PMID: 36405936
Background: Evidence on the financial experiences of cancer survivors living in settings with pluralistic health systems remains limited. We explored the out-of-pocket costs, the resulting financial impact and the coping...
5.
Kong Y, Kimman M, Subramaniam S, Yip C, Jan S, Aung S, et al.
Lancet Glob Health . 2022 Feb; 10(3):e416-e428. PMID: 35180423
Background: Complementary medicine, which refers to therapies that are not part of conventional medicine, comprising both evidence-based and non-evidence-based interventions, is increasingly used following a diagnosis of cancer. We aimed...
6.
Subramaniam S, Kong Y, Zaharah H, Uiterwaal C, Richard A, Taib N, et al.
Ecancermedicalscience . 2021 Nov; 15:1293. PMID: 34824616
Purpose: To measure the baseline prevalence of cardiovascular disease (CVD), its modifiable and non-modifiable risk factors in breast cancer patients, and determine their association with adjuvant treatment decision-making. Method: From...
7.
Bhoo-Pathy N, Subramaniam S, Khalil S, Kimman M, Kong Y, Ng C, et al.
JCO Oncol Pract . 2021 Jun; 17(10):e1592-e1602. PMID: 34077232
Purpose: To determine household spending patterns on complementary medicine following cancer and the financial impact in a setting with universal health coverage. Methods: Country-specific data from a multinational prospective cohort...
8.
Khoo S, Shafii M, Bhoo-Pathy N, Yap S, Subramaniam S, Nasir N, et al.
PLoS One . 2021 Jan; 16(1):e0245731. PMID: 33471825
Background: Addressing the burden of HPV-associated diseases among men is increasingly becoming a public health issue. The main objective of this study was to determine HPV prevalence among a healthy...
9.
Kong Y, Rauf N, Subramaniam S, Bustamam R, Wong L, Ho G, et al.
J Cancer Surviv . 2020 Oct; 15(5):706-712. PMID: 33094415
Purpose: A considerable proportion of individuals who are diagnosed with cancer are at a working age. We aimed to gain an in-depth understanding of the challenges, and arising needs related...
10.
Wong L, Kong Y, Bhoo-Pathy N, Subramaniam S, Bustamam R, Taib N, et al.
JCO Oncol Pract . 2020 Sep; 17(4):e548-e555. PMID: 32986532
Purpose: The breaking of news of a cancer diagnosis is an important milestone in a patient's cancer journey. We explored the emotional experiences of patients with cancer during the breaking...